A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Clinical trial NCT04838847 · WITHDRAWN

Trial details

NCT number: NCT04838847
Sponsor: CureVac
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Covid19 SARS-CoV-2 Severe Acute Respiratory Syndrome

Start date: 2021-10-01
Primary completion: 2022-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.